PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Search This Blog

Loading...

Monday, August 11, 2014

merck3

custom search

REVERSED
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2453 Ex Parte COCKS et al 11459944 - (D) DILLON 103 GRASSO PLLC SCOTT, RANDY A

Tech Center 2600 Communications
2668 Ex Parte MENDONCA et al 11558715 - (D) BAUMEISTER 102/103 37 CFR 41.50(b) 101 HINMAN, HOWARD & KATTELL, LLP ABDI, AMARA

The Examiner's interpretation would likewise render the expressly recited claim term "probabilistic" superfluous.  Such an interpretation would be contrary to the canons of claim construction.  "A claim construction that gives meaning to all the terms of the claim is preferred over one that does not do so." Merck & Co. v. Teva Phams. USA, Inc., 395 F.3d 1364, 1372 (Fed. Circ. 2005). We therefore find the Examiner's claim construction of  "a probabilistic model" unreasonable broad.

Merck & Co., Inc., v. Teva Pharms. USA, Inc., 395 F.3d 1364, 73 USPQ2d 1641 (Fed. Cir. 2005) 2111.01

AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1766 Ex Parte Yarovesky 12115967 - (D) OWENS 102/103 103 KELLY & KELLEY, LLP SZEKELY, PETER A

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3771 Ex Parte Mythen 11885472 - (D) FREDMAN 112(2)/103 103 LOUIS WOO STUART, COLIN W

AFFIRMED
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2847 Ex Parte Lauffer et al 12078206 - (D) NAGUMO 103 HINMAN, HOWARD & KATTELL, LLP SAWYER, STEVEN T

2851 Ex Parte Hopkins et al 12349289 - (D) GARRIS 101/102/103 Russell Ng PLLC (IBM AUS) LEE, ERIC D

No comments :